Patent · US Active

Compositions comprising siRNA and plasmids

US8703929B2 · kind B2 · utility

0Cited by
5References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 9, 2009
Grant dateApr 22, 2014
Priority date
Expiry dateMar 9, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/31
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to the combinatorial use of an siRNA targeted against an endogenous gene to knock out or knock down expression of the endogenous gene in a host and a delivery of a polynucleotide encoding the gene in a delivery vehicle/expression vector to the host to provide expression in the host of the protein encoded by the polynucleotide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.